From April 7 to 10, 2023, the 2023 World Health Expo (hereinafter referred to as “the Expo”) was grandly held in Wuhan. As a highly influential industry event in the global health sector, this Expo gathered thousands of health‑industry enterprises worldwide, displaying cutting‑edge achievements covering medical technology, biomedicine, medical consumables, smart healthcare and other fields. As a professional enterprise specializing in the R&D, production of medical consumables and minimally‑invasive medical devices, Medisen brought three flagship products — scar gel, single‑use medical laser optical fiber and automatic circumcision ring — to Booth A3‑B17. Boasting solid product technical strengths and a professional brand image, Medisen became one of the highlights in the medical‑consumables exhibition area.

Industry Event: 2023 World Health Expo Builds a High‑Ground for Health‑Industry Exchanges

Overall Scale and Industry Positioning of the Expo

Under the theme “Health Community, Technology Shaping the Future”, the 2023 World Health Expo focuses on cutting‑edge technologies and innovative achievements of the global health industry. It serves as a comprehensive industrial platform integrating product exhibition, technical exchange, trade cooperation and academic seminars. Covering an exhibition area of over 100,000 square meters, the Expo set up multiple specialized zones including international medical care & elderly care, medical devices, biomedicine, traditional medicine and health management. It attracted more than one thousand enterprises from over 30 countries and regions around the globe, drawing hundreds of thousands of professional visitors. It ranks among the largest and most influential health‑industry expos in central China.

For the medical device and consumable sector, the Expo is not only a product showcase, but also a core hub for matching clinical demands, identifying industry trends and connecting upstream and downstream resources. Numerous medical institutions, distributors, foreign purchasers and clinical experts gathered onsite for in‑depth discussions on key topics such as safety, effectiveness and convenience of medical consumables, promoting the transformation of technical achievements into clinical applications.

Rising Industry Attention for the Medical Consumables Exhibition Area

Among multiple exhibition zones of the Expo, the medical consumables and minimally‑invasive device pavilion drew large crowds of professional visitors thanks to its high professionalism and clinical relevance. With the improvement of domestic medical services and advancement of tiered diagnosis and treatment, clinical demand for high‑quality, safe single‑use medical consumables and minimally‑invasive devices keeps growing. Technical iteration and market expansion of such products have become core focuses of the industry.

Policy Initiatives Drive Standardized Development of the Medical Consumables Industry

In recent years, the state has rolled out a series of policies to boost high‑quality development of the medical‑consumables industry. Guidelines covering optimized registration & approval, upgraded quality supervision and volume‑based procurement steer the industry toward standardization and innovation. Against this backdrop, enterprises with independent R&D capabilities and strict quality‑control systems gain competitive edges. Technical content and clinical value of products have become core pillars for enterprises to survive in the market.

Medisen’s Participation: Professional Brand Presence at the 2023 World Health Expo

Medisen’s Brand Positioning and Development Direction

Hall A3 where Medisen was located hosted many premium domestic medical device and consumable manufacturers. Medisen’s offerings spanned multiple niche segments including wound repair, surgical instruments, interventional consumables and laser medical treatment.

Medisen is a modern medical‑device enterprise dedicated to the R&D, production and sales of medical consumables and minimally‑invasive surgical instruments. Centered on clinical demands, the company commits itself to delivering safe, efficient and convenient medical product solutions for medical institutions and patients. Since its founding, Medisen has delved deep into niche sectors: wound repair, laser‑medical consumables and urological minimally‑invasive instruments. Supported by standardized production systems and rigorous R&D workflows, it has launched multiple market‑recognized medical products.

In product R&D and manufacturing, Medisen strictly complies with the Regulations on the Supervision and Administration of Medical Devices and relevant Good Manufacturing Practices. It has built a full‑process quality‑control system covering raw‑material procurement, manufacturing, finished‑product inspection, warehousing and logistics to ensure all products meet compliance requirements and quality standards. Participation in the 2023 World Health Expo marks a key move for Medisen to demonstrate product strengths and connect with market resources, and reflects its resolve to expand business footprint in the health sector.

Booth Design: Professional and Minimalist, Highlighting Core Product Value

At Booth A3‑B17, Medisen displayed its three core products, alongside consultation and brochure‑collection zones for visitors to learn about product details. On‑site professional technical and business teams provided detailed product‑parameter briefings, clinical‑application explanations and cooperation consultations for attendees.

During the Expo, Medisen’s booth attracted numerous visitors from hospitals, clinics, medical‑device distributors and overseas purchasers with its clear product positioning and professional services. Many clinical medical staff exchanged views with technicians on product usage details and applicable scenarios, while distributors focused on compliance qualifications, supply capacity and cooperation policies. On‑site communications were vibrant.

Three Products Address Multi‑Dimensional Clinical Needs

The three flagship products unveiled by Medisen at the Expo are developed to solve real‑world clinical pain points. They cover three clinical segments: wound repair, laser medical treatment and urology, demonstrating the enterprise’s product layout and technical accumulation in niche medical‑consumable sectors.

Scar Gel: Refined Care Solution for Wound Repair

Scar gel is Medisen’s core offering in the wound‑repair segment. It is intended for scar care after skin wound healing, and widely used in dermatology, burn departments, plastic surgery and post‑operative care.

Product Mechanism and Core Features

Formulated with silicone as the key ingredient, the scar gel forms a breathable protective film on skin surface. It maintains hydration of scar tissue, regulates normal collagen metabolism, and therefore softens scars, flattens hyperplastic lesions and improves scar color and appearance. Boasting a mild formula suitable for most skin types, the gel feels fresh and non‑sticky for convenient home‑use patient care.

Scope of Application and Clinical Scenarios

The scar gel applies to hypertrophic scars and keloids caused by surgery, trauma, burns and scalds. It can be adopted in hospital departments including dermatology, plastic surgery, burn surgery and general surgery, as well as for continuous home‑care after hospital discharge. Early application after wound healing can effectively lower risks of scar hyperplasia and improve post‑healing skin appearance.

Single‑use Medical Laser Optical Fiber: Core Matching Consumable for Precise Laser Therapy

Single‑use medical laser optical fiber is Medisen’s key product in laser‑medical consumables. As an essential matching consumable for laser therapeutic equipment, it is widely used in minimally‑invasive laser surgeries across urology, dermatology, otolaryngology, general surgery and other departments.

Technical Features and Performance Advantages

Made of high‑quality fiber materials, the single‑use medical laser optical fiber delivers high‑efficiency laser transmission and stable energy output to guarantee accurate and effective treatment. Subjected to strict production processes and quality inspections, it features smooth and clean end faces and safe and reliable sheaths, compatible with mainstream medical laser therapeutic devices on the market.

As a single‑use product, it realizes “one‑patient‑one‑use” to fundamentally avoid cross‑infection and satisfy hospital infection‑control requirements. Individually packed in sterile packaging, it facilitates clinical storage and application. Re‑sterilization is unnecessary, helping medical staff boost work efficiency and reduce operational costs for medical departments.

Multi‑Department Clinical Application Scenarios

In urology, the fiber works with laser devices for lithotripsy of urinary calculi and benign prostatic hyperplasia treatment. In dermatology, it supports laser therapies for pigmented lesions, vascular lesions and hair removal. It also meets diverse laser‑treatment demands in otolaryngology, stomatology and general surgery. Its broad compatibility satisfies consumable‑procurement requirements of medical institutions at all levels across multiple departments.

Automatic Circumcision Ring: Standardized Minimally‑Invasive Instrument for Urological Treatment

The automatic circumcision ring is a minimally‑invasive instrument developed by Medisen for circumcision procedures. Its standardized design streamlines surgical workflows, improves surgical efficiency and enhances patients’ post‑operative experience.

Design Principle and Operating Workflow

Featuring an inner‑and‑outer‑ring structure, the automatic circumcision ring blocks blood supply to redundant foreskin via ligation, leading to its natural necrosis and shedding to complete circumcision. Compared with traditional surgical approaches, it simplifies procedures, shortens operation time, reduces intraoperative bleeding and eases post‑operative care. Patients do not require frequent dressing changes, and suffer less disruption to daily work and life.

Core Advantages in Clinical Practice

For clinicians, its standardized design lowers surgical barriers and improves procedure consistency, making it suitable for circumcision operations in urology, andrology departments and primary clinics across medical institutions of all tiers. For patients, the minimally‑invasive approach brings minimal trauma, mild pain and neat post‑operative appearance, greatly improving medical experience. It represents one of the widely‑adopted circumcision solutions in current clinical practice.

Multi‑Dimensional On‑Site Communication and Business Matching

During the four‑day Expo, Medisen’s Booth A3‑B17 received hundreds of professional visitors nationwide, including procurement officers from medical institutions, clinicians, regional distributors and foreign purchasers. Attendees raised detailed inquiries covering technical parameters, clinical applications, cooperation modes and supply assurance from their respective perspectives, and received professional, thorough responses from Medisen’s on‑site team.

Many clinical medical staff acknowledged the product clinical value after learning about the offerings, and put forward valuable optimization suggestions drawing on their hands‑on clinical experience. Front‑line feedback will serve as important references for Medisen’s subsequent product iteration.

Beyond product display and client engagement, Medisen’s team took part in multiple industry forums and technical‑exchange events at the Expo to gain insights into policy orientations, technical trends and market dynamics of the health industry. Communications with peer enterprises and industry experts helped Medisen clarify development directions for medical consumables, and consolidated its corporate strategy of pursuing technological innovation and quality‑oriented growth.

Through this Expo, Medisen established initial contacts with multiple prospective distributors and purchasers, and further follow‑up on cooperation details will be carried out.

Expanding Product Portfolio and Deepening Layout in Niche Segments

Medisen will continue to focus on core tracks: wound repair, laser‑medical consumables and minimally‑invasive surgical instruments. It will increase R&D investment, optimize performance of existing products, and launch more new products addressing clinical demands to enrich its product portfolio and deliver more comprehensive medical‑consumable solutions for clients.

The enterprise will maintain close communication with clinical end‑users, so that R&D is always driven by real clinical needs. Every product is expected to deliver tangible clinical value, help medical staff improve diagnosis‑treatment efficiency, and bring better therapeutic outcomes for patients.

Upholding Quality and Compliance, Fulfilling Corporate Social Responsibility

As a medical‑device enterprise, safeguarding product safety and effectiveness and protecting public health constitute its core responsibility. Medisen will keep its commitment to quality benchmarks, strictly abide by industry regulatory requirements, and continuously optimize its quality‑management system to serve clinical practice and patients with high‑quality products. Meanwhile, it will actively participate in industry exchanges and public‑welfare activities to contribute to high‑quality development of the health industry.

Participation in the 2023 World Health Expo has demonstrated Medisen’s product strengths and brand image to the industry, while yielding valuable market feedback and cooperation resources.

Frequently Asked Questions

Q1: What is Medisen’s booth number at the 2023 World Health Expo?

A: Medisen’s booth number is A3‑B17 in the medical‑consumables zone. The Expo ran from April 7 to April 10, 2023.

Q2: What core products did Medisen showcase at the Expo?

A: Medisen presented three core medical products: scar gel, single‑use medical laser optical fiber and automatic circumcision ring. They cover three clinical scenarios: wound repair, laser‑medical consumables and urological minimally‑invasive instruments.

Q3: What are the application scenarios for Medisen’s scar gel?

A: Medisen scar gel is used for care of hypertrophic scars and keloids resulting from surgery, trauma, burns and scalds. It shall be used only after wounds are fully healed. It softens scars and improves scar appearance. It can be used in hospital departments such as dermatology, plastic surgery and burn surgery, as well as for home‑based care.

Q4: What are the core advantages of single‑use medical laser optical fiber?

A: Made of high‑quality fiber materials, the single‑use medical laser optical fiber features stable and efficient laser transmission and fits laser therapies in multiple departments. As a sterile single‑use product, it prevents cross‑infection and meets hospital infection‑control standards. No re‑sterilization is required, which improves clinical work efficiency.

Q5: What characteristics does the automatic circumcision ring have compared with traditional surgery?

A: Working on the ligation principle, the automatic circumcision ring enables simple and fast operations with less intraoperative bleeding. Post‑operative care is simplified. Patients suffer milder pain and achieve neat post‑operative appearance. It improves surgical efficiency and patient medical experience, and is applicable to medical institutions of all levels.

Q6: Do Medisen’s products hold valid medical‑device compliance certifications?

A: As a formal medical‑device manufacturer, Medisen strictly follows national medical‑device regulatory rules. Its relevant products have completed required registration and filing procedures with valid medical‑device registration certificates. Production complies with Good Manufacturing Practice for medical devices.

Q7: How can I inquire about cooperation opportunities for Medisen’s products?

A: Prospective clients who want to know more about products or cooperation terms may contact Medisen’s business team via official channels to obtain detailed product documents, qualification certificates and cooperation policies.

Q8: What is Medisen’s future product development direction?

A: Medisen will keep focusing on medical consumables and minimally‑invasive devices. It will optimize existing products based on real clinical demands, expand its product pipeline, strengthen its layout in wound repair, laser consumables and minimally‑invasive surgery, and deliver more premium clinical solutions.